257 results on '"Mazzi B"'
Search Results
2. Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves’ disease and Graves’ orbitopathy
3. Exocrine pancreas function is impaired in adult relatives of patients with type 1 diabetes
4. Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study
5. Use of low-dose radioiodine ablation for Graves’ orbitopathy: results of a pilot, perspective study in a small series of patients
6. Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma
7. POS1418 ANTIGEN-SPECIFIC T-CELL DYNAMICS AND MULTIDIRECTIONAL IMMUNE DYSREGULATION IN SLE
8. Quantitative polymerase chain reaction-based chimerism in bone marrow or peripheral blood to predict acute myeloid leukemia relapse in high-risk patients: Results from the KIM-PB prospective study
9. Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves’ orbitopathy
10. Longitudinal qPCR monitoring of nucleophosmin 1 mutations after allogeneic hematopoietic stem cell transplantation to predict AML relapse
11. A Novel Assay in Whole Blood Demonstrates Restoration of Mitochondrial Activity in Phagocytes After Successful HSCT in Hyperinflamed X-Linked Chronic Granulomatous Disease
12. Long-term outcome of Graves’ orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapy
13. Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation
14. Use of DPB1 T-cell epitope algorithm among italian transplant centers: A survey on behalf of Associazione Italiana di Immunogenetica e Biologia dei Trapianti
15. The conundrum of HLA-DRB1*14:01/*14:54 and HLA-DRB3*02:01/*02:02 mismatches in unrelated hematopoietic SCT
16. Thyroglobulin autoantibodies switch to immunoglobulin (Ig)G1 and IgG3 subclasses and preserve their restricted epitope pattern after 131I treatment for Gravesʼ hyperthyroidism: the activity of autoimmune disease influences subclass distribution but not epitope pattern of autoantibodies
17. NON-LINEAR CLONAL EVOLUTION OF LEUKEMIA DRIVEN BY THE SELECTIVE IMMUNE PRESSURE OF ALLOGENEIC HSCT: PH-O014
18. Genomic typing for patient-specific human leukocyte antigen-alleles is an efficient tool for relapse detection of high-risk hematopoietic malignancies after stem cell transplantation from alternative donors
19. Bone marrow mammaglobin expression as a marker of graft-versus-tumor effect after reduced-intensity allografting for advanced breast cancer
20. High-sensitivity haematopoietic chimerism by qPCR for relapse prediction and specific identification of HLA loss leukaemic variants: O403
21. A shell-model approach to fractal-induced turbulence
22. Genotypes and haplotypes in the 3′ untranslated region of the HLA-G gene and their association with clinical outcome of hematopoietic stem cell transplantation for beta-thalassemia
23. The conundrum of HLA-DRB1*14:01/*14:54 and HLA-DRB3*02:01/ *02:02 mismatches in unrelated hematopoietic SCT
24. Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves’ orbitopathy
25. SAT0231 MULTIDIRECTIONAL DYSFUNCTION OF THE IMMUNE RESPONSE IN SYSTEMIC LUPUS ERYTHEMATOSUS
26. Linking allergy to mercury to HLA and burning mouth syndrome
27. Bone marrow mammaglobin expression as a tool for assessing micrometastatic disease after reduced-intensity allografting for advanced breast cancer
28. Rapid detection of all HLA-B*27 alleles (B*2701–B*2725) by group-specific polymerase chain reaction
29. Molecular characterization of HLA class I in Colombians carrying HLA-A2: high allelic diversity and frequency of heterozygotes at the HLA-B locus
30. HLA-A*02 subtype distribution in Caucasians from northern Italy: identification of A*0220
31. Follow-up study on PCR-SSOP typing of the HLA-A locus: improved resolution of A-10 and A-19 splits
32. DROPLET DIGITAL PCR FOR DNMT3A AND IDH1/2 MUTATIONS TO IMPROVE EARLY DETECTION OF ACUTE MYELOID LEUKEMIA RELAPSE AFTER ALLOGENEIC HSCT
33. Neuromyelitis optica spectrum disorder and multiple sclerosis in a Sardinian family
34. Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves’ disease and Graves’ orbitopathy
35. Rehabilitative orbital decompression for Graves’ orbitopathy: results of a randomized clinical trial
36. NON-LINEAR CLONAL EVOLUTION OF LEUKEMIA DRIVEN BY THE SELECTIVE IMMUNE PRESSURE OF ALLOGENEIC HSCT
37. Droplet Digital PCR for DNMT3A and IDH1/2 Mutations to Improve Early Diagnosis of Acute Myeloid Leukemia Relapse after Allogeneic HSCT
38. HLA-G Polymorphisms And Outcome Of Allogeneic Stem Cell Transplantation For Metastatic Renal Cell Cancer
39. Use of low-dose radioiodine ablation for Graves’ orbitopathy: results of a pilot, perspective study in a small series of patients
40. Incidence, Risk Factors and Clinical Outcome Of Leukemia Relapses Due To Loss Of The Mismatched HLA Haplotype After Partially-Incompatible Hematopoietic Stem Cell Transplantation
41. Loss of mismatched HLA at leukaemia relapse after haematopoietic stem cell transplantation is significantly associated with clinical and immunogenetic hallmarks of donor-versus-host alloreactivity
42. High-Sensitivity Hematopoietic Chimerism By qPCR For Relapse Prediction and Specific Identification Of HLA Loss Leukemic Variants
43. Non-Linear Clonal Evolution Of Leukemia Driven By Selective Immune Pressure and Revealed By HLA Typing and High-Depth Exome Sequencing
44. GENOMIC LOSS OF PATIENT-SPECIFIC HLA-DPB1 IN LEUKEMIA AFTER MISMATCHED HEMATOPOIETIC STEM CELL TRANSPLANTATION CAN BE DETECTED BY QUANTITATIVE PCR IN A SINGLE ASSAY
45. Quantitative PCR for Ins/Del polymorphisms is a reliable and sensitive tool for host chimerism analysis after allogeneic hamatopoietic stem cell transplantation
46. Loss of Mismatched HLA At Leukemia Relapse After Hematopoietic Stem Cell Transplantation Is Significantly Associated with Clinical and Immunogenetic Hallmarks of Donor-Versus-Host Alloreactivity
47. GENOMIC LOSS OF PATIENT-SPECIFIC HLA IN LEUKEMIC BLASTS CAN PROMPT IMMUNE EVASION AND CLINICAL RELAPSE OF ACUTE MYELOID LEUKEMIA AFTER WELL-MATCHED UNRELATED DONOR HSCT
48. Quantitative PCR for ins/del polymorphisms is a reliable and sensitive tool for host chimerism analysis after allogeneic hematopoietic stem cell transplantation
49. Loss of mismatched HLA as a mechanism of leukaemia immune escape in family haploidentical and unrelated haematopoietic stem cell transplantation
50. Timing and rate of success in transplant of matched unrelated donor (MUD) searches through bone marrow donors worldwide (BMDW): the case of San Raffaele Institute in 2006-2009
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.